Compass Therapeutics, Inc. Provides Corporate Update
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Compass Therapeutics, Inc., a clinical-stage biotechnology company developing proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies, today announced the...









